Author:
Kaufmann M.,von Minckwitz G.,Scharl A.,Costa S. D.
Publisher
Springer Berlin Heidelberg
Reference188 articles.
1. Ahr A, Kahn T, Solbach C, Seiter T, Strelhardt K, Holtrich H, Kaufmann M (2002) Identification of high risk breast cancer patients by gene expression profiling. Lancet 359: 131–133
2. Albain KS, Nag S, Calderillo-Ruiz G, Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall survival. Proc ASCO 22, 14S (Abstr 510)
3. Batson OV (1967) The vertebral system of veins as a means for cancer dissemination. Prog Clin Cancer 3: 1–18
4. Bear HD, Anderson S, Smith RE et al. (2004) A randomized trial comparing preoperative (preop) doxorubicin/cyclophosphamide (AC) to preop AC followed bei preop docetaxel (T) and to preop AC followed by postoperative (postop) T in patients (pts) with operable carcinoma of the breast: results of NSABP B-27. Breast Cancer Res Treat 88: 16 (Abstr)
5. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestion for a new method of treatment, with illustrative cases. Lancet II(104): 162